Abstract: The present invention relates to the use of a nasal spray made from Cistus extracts for the prevention and/or treatment of viral and/or bacterial diseases of the oral and pharyngeal cavities.

Abstract: The invention relates to a laxative with improved compliance, containing polyethylene glycol (PEG). A medicinal product according to the invention is suitable for treating chronic obstipations and is characterized in that it comprises two components, A and B, which are spatially separated from one another, component A comprising a polyethylene glycol (PEG) and component B comprising at least one electrolyte.

Abstract: The invention relates to a medicinal product which is free from sympathomimetics, has an advantageous effect on the nasal mucosa in case of common colds, hay fever, dry nose and sympathomimetic dependencies, and is provided in the form of a nasal spray, a nasal douche or nasal drops.

Abstract: The present invention relates to the use of a nasal spray made from Cistus extracts for the prevention and/or treatment of viral and/or bacterial diseases of the oral and pharyngeal cavities.

Abstract: The present invention relates to the use of a nasal spray made from Cistus extracts for the prevention and/or treatment of viral and/or bacterial diseases of the oral and pharyngeal cavities.

Abstract: The invention relates to peroral solid analgesic formulations containing opioids and/or morphine analogues in an effect-retarding matrix.

Abstract: The present invention relates to orally administerable medicinal plant dry extracts, wherein the non-volatile phase of the extract is bound in a microdisperse form and/or in the form of a semisolid or solid solution to a first carrier which is soluble in or miscible with alcohol, soluble in or miscible with water and solid at room temperature, optionally in addition to other auxiliaries and/or additives. Optionally, a second carrier is selected from carriers which are insoluble in alcohol, insoluble in water or swellable in water and solid at room temperature, or alkaline earth metal and/or alkali metal carbonates including hydrogencarbonates.

Abstract: The invention relates to pellet formulations which (a) contain at least one active compound, one binder and one weighting agent, (b) are coated with a lacquer which is resistant to gastric juice or have been granulated in the presence of a lacquer which is resistant to gastric juice, it being possible, if appropriate, for the granules to be coated with a lacquer which is resistant to gastric juice, (c) have an apparent density of 1.4 to 2.4 and (d) have a diameter of 0.2 to 1.8 mm.

Abstract: The invention relates to topical antiinflammatory medicament formulations which also have analgesic activity and contain 2-(2-hydroxyethoxy)-ethyl N-(.alpha.,.alpha.,.alpha.,-trifluoro-m-tolyl) anthranilate as the active ingredient and an adjuvant which is preferably a triglyceride.

Abstract: The invention relates to depot formulations containing, as an active antiinflammatory and/or analgesic agent a compound of Formula I, infra together with a suspension medium. Typical suspension agents are glycerides and/or esters of mono- or poly-hydric alcohols as well as selected ethers, alcohols and amides.

Abstract: The invention relates to depot formulations containing, as an active antiinflammatory and/or analgesic agent a compound of Formula I, infra together with a suspension medium. Typical suspension agents are glycerides and/or esters of mono- or poly-hydric alcohols as well as selected ethers, alcohols and amides.